Corino Therapeutics, Inc. — Form D
Corino Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-27. The offering totals $5.0M, of which $3.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-04-27
- Form: D
- Accession: 0001703341-17-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.5M
- Remaining: $1.5M
- Investors: 27
- Date of first sale: 2017-04-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-285612
Issuer
- Name: Corino Therapeutics, Inc.
- CIK: 0001703341
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: PETER BARBER, NEW YORK, NY, 10019
- Phone: (212) 430-1740
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Peter Barber | Director | New York, NY |
| Daniel DiPietro | Director | New York, NY |
| Timothy McInerney | Director | New York, NY |
| Jay Moorin | Director | New York, NY |
| Daniel DiPietro | Executive Officer | New York, NY |
More